This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1982 Dec;142(13):2293-4.

doi: 10.1001/archinte.142.13.2293.

Systemic effects of eye drops

A G Adler, G E McElwain, G J Merli, J H Martin

PMID: 7149872
DOI: 10.1001/archinte.142.13.2293

Systemic effects of eye drops

A G Adler et al. Arch Intern Med. 1982 Dec.

. 1982 Dec;142(13):2293-4.

doi: 10.1001/archinte.142.13.2293.

Authors

A G Adler, G E McElwain, G J Merli, J H Martin

PMID: 7149872
DOI: 10.1001/archinte.142.13.2293

No abstract available

PubMed Disclaimer

Similar articles

Adverse systemic reactions of ocular drops.
Orlando RG. Orlando RG. Ohio State Med J. 1984 Oct;80(10):747-9. Ohio State Med J. 1984. PMID: 6504442 No abstract available.
How safe are ocular drugs in pediatrics?
Palmer EA. Palmer EA. Ophthalmology. 1986 Aug;93(8):1038-40. doi: 10.1016/s0161-6420(86)33624-8. Ophthalmology. 1986. PMID: 3763151
Systemic side effects associated with the ophthalmic administration of timolol.
Munroe WP, Rindone JP, Kershner RM. Munroe WP, et al. Drug Intell Clin Pharm. 1985 Feb;19(2):85-9. doi: 10.1177/106002808501900201. Drug Intell Clin Pharm. 1985. PMID: 3882377 Review.
Cholinergic toxicity resulting from ocular instillation of echothiophate iodide eye drops.
Manoguerra A, Whitney C, Clark RF, Anderson B, Turchen S. Manoguerra A, et al. J Toxicol Clin Toxicol. 1995;33(5):463-5. doi: 10.3109/15563659509013755. J Toxicol Clin Toxicol. 1995. PMID: 7650771
Ocular toxicology update.
Fraunfelder FT, Meyer SM. Fraunfelder FT, et al. Aust J Ophthalmol. 1984 Nov;12(4):391-4. doi: 10.1111/j.1442-9071.1984.tb01186.x. Aust J Ophthalmol. 1984. PMID: 6397176 Review.

See all similar articles

Cited by

Systemic and local tolerability of ophthalmic drug formulations. An update.
Hugues FC, Le Jeunne C. Hugues FC, et al. Drug Saf. 1993 May;8(5):365-80. doi: 10.2165/00002018-199308050-00004. Drug Saf. 1993. PMID: 8099291 Review.
Oxidation phenotype and the metabolism and action of beta-blockers.
Lennard MS. Lennard MS. Klin Wochenschr. 1985 Apr 1;63(7):285-92. doi: 10.1007/BF01731972. Klin Wochenschr. 1985. PMID: 2860267 Review.
Ocular phenylephrine 2.5% continues to be dangerous.
Ahmed N, Riad W, Altorpaq A, Zahoor A. Ahmed N, et al. BMJ Case Rep. 2009;2009:bcr08.2008.0795. doi: 10.1136/bcr.08.2008.0795. Epub 2009 Mar 2. BMJ Case Rep. 2009. PMID: 21686626 Free PMC article.
Mental status changes induced by eye drops in dementia of the Alzheimer type.
Reyes PF, Dwyer BA, Schwartzman RJ, Sacchetti T. Reyes PF, et al. J Neurol Neurosurg Psychiatry. 1987 Jan;50(1):113-5. doi: 10.1136/jnnp.50.1.113. J Neurol Neurosurg Psychiatry. 1987. PMID: 3819748 Free PMC article. No abstract available.
Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.
Cimolai N. Cimolai N. Clin Med Res. 2019 Dec;17(3-4):90-96. doi: 10.3121/cmr.2019.1486. Epub 2019 Aug 28. Clin Med Res. 2019. PMID: 31462538 Free PMC article. Review.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems